The new NICE guideline – a summary and discussion of the draft
On 10 November 2020, the National Institute for Health and Care Excellence (NICE) published a
Continue readingThe new NICE guideline – a summary and discussion of the draft
A critical view into ME/CFS research
On 10 November 2020, the National Institute for Health and Care Excellence (NICE) published a
Continue readingThe new NICE guideline – a summary and discussion of the draft
Evelien and I recently made an overview of ongoing or planned clinical trials for ME/CFS. We
Continue readingProgress is happening: an overview of positive developments in the ME/CFS community
Evelien and I recently made an overview of clinical trials for ME/CFS that are in
Continue readingA disease funding comparison: is ME/CFS getting too little?
The research team that is studying ME/CFS at the National Institutes of Health (NIH) has
Continue readingSummary of the NIH’s exploration of post-exertional malaise
I’ve tried to make a preliminary overview of (extramural) NIH grants for ME/CFS research for
What clinical trials are currently planned or ongoing for ME/CFS? It can take many years
Continue readingWhat’s in the pipeline? Ongoing, registered, or planned clinical trials for ME/CFS
Problems with the amended version (Version published: 02 October 2019) part I. I appreciate the
Continue readingMy comments to the Cochrane review on exercise therapy for CFS
On Wednesday, October 2, Cochrane published a long-awaited amendment to its review of exercise therapy
Blinding, sometimes called masking, is the process of keeping key persons involved in the conduct
Yesterday, the Guardian’s Science Weekly podcast published an update of its episode titled: “What role
Continue readingThe Guardian’s Science Weekly podcast and the Cochrane review